CROXX MED ApS: Financial statements 2023
CVR: 33247117
Source: annual report 2023, Danish Business Authority
01/07/2022 – 30/06/2023
CROXX MED ApS (CVR 33247117) has filed annual accounts for 2023. In 2023, the company reported a gross profit of DKK 6,364,871 and a net result of DKK 927,550 compared with DKK 2,476,756 the year before. That is a decrease of 20.5% compared with the year before. Equity in the 2023 report amounted to DKK 2,302,816. The solvency ratio was 60.9%. The company had 5 employees in the financial year.
- Gross Profit
- DKK 6,364,871
- Profit/Loss
- DKK 927,550
- Equity
- DKK 2,302,816
- Total Assets
- DKK 3,781,970
- Employees
- 5
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2023 | - | 6.4M | 928K | 2.3M | 5 |
| 2022 | - | 8M | 2.5M | 2.9M | 6 |
| 2021 | - | 6.9M | 1.7M | 1.4M | 5 |
| 2020 | - | 4.9M | 933K | 1.6M | 4 |
| 2019 | - | 4.4M | 899K | 681K | 4 |
Official annual report
Fetch this data via API
Every Danish company, financial statement and ownership record, straight into your own systems or your AI assistant via MCP.
See the API documentationAbout CROXX MED ApS
CROXX MED ApS is a Danish company of the type Anpartsselskab based in Hørsholm, founded in 2010. The company is registered under the industry Andre liberale, videnskabelige og tekniske tjenesteydelser i.a.n.. The management consists of Birgitte Telmer. The company is owned by CROXXMED HOLDING ApS and I-S-A HOLDING ApS. The company has 5 employees (2026). In 2025, the company reported a gross profit of DKK 4,710,670 and a net result of DKK 121,337 compared with DKK 2,315,478 the year before. Equity in the 2025 report amounted to DKK 2,339,631.